These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effectiveness of BC meningococcal vaccine in Brazil. Nishioka S Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501 [No Abstract] [Full Text] [Related]
6. Safety of group C meningococcal vaccine. Commun Dis Rep CDR Wkly; 2000 Sep; 10(35):311, 314. PubMed ID: 10992627 [No Abstract] [Full Text] [Related]
7. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic]. Wu C Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683 [No Abstract] [Full Text] [Related]
8. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?]. Rød KA Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367 [No Abstract] [Full Text] [Related]
9. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
10. Vaccines against meningococcal meningitis: current status. Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300 [No Abstract] [Full Text] [Related]
11. Indications for use of meningococcal vaccine. Peltola H J Pediatr; 1980 Aug; 97(2):330-2. PubMed ID: 6772752 [No Abstract] [Full Text] [Related]
12. [The new Norwegian meningococcal vaccine]. Bjune G Tidsskr Nor Laegeforen; 1987 Nov; 107(32):2868-9. PubMed ID: 3122361 [No Abstract] [Full Text] [Related]
13. Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Bosmans E; Vimont-Vicary P; Andre FE; Crooy PJ; Roelants P; Vandepitte J Ann Soc Belg Med Trop; 1980 Sep; 60(3):297-306. PubMed ID: 6788001 [No Abstract] [Full Text] [Related]
14. Right age for Meningococcal vaccine. John TJ Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680 [No Abstract] [Full Text] [Related]
15. Safety of meningococcal polysaccharide vaccine serogroup "A" (Pilot Study). Bahl MR Med J Zambia; 1975 Dec-1976 Jan; 9(6):166. PubMed ID: 818845 [TBL] [Abstract][Full Text] [Related]
16. Potential of the adhesin complex protein of Neisseria meningitidis for next-generation meningococcal vaccines. Hung MC; Heckels JE; Christodoulides M Expert Rev Vaccines; 2013 Sep; 12(9):981-4. PubMed ID: 24053391 [No Abstract] [Full Text] [Related]
17. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A]. Yuan CD Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682 [No Abstract] [Full Text] [Related]
18. [A controlled trial with 2 anti-Neisseria B meningitidis vaccines and placebo in Chilean population]. Herrera P; Lagos R Rev Med Chil; 1998 Nov; 126(11):1403-4. PubMed ID: 10349187 [No Abstract] [Full Text] [Related]
19. Commentary: prophylaxis for contacts of patients with meningococcal disease. Gold R Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315 [No Abstract] [Full Text] [Related]
20. [Anti-meningococcal vaccines]. Taha MK; Alonso JM Rev Prat; 2008 Dec; 58(19):2099-101. PubMed ID: 19213536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]